Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 5Myelodysplastic Syndromes 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Sezary Syndrome 1Recurrence 1Mycoses 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1

Interventions

Peripheral Blood Stem Cell Transplantation 36fludarabine phosphate 32Cyclophosphamide 30Mycophenolic Acid 26Whole-Body Irradiation 23Tacrolimus 22Cyclosporine 20Busulfan 16Antilymphocyte Serum 16Methotrexate 14Radiotherapy 13Filgrastim 12Flow Cytometry 11Etoposide 11Methylprednisolone 8Melphalan 8Therapeutics 7Rituximab 7Lenalidomide 7Psychiatric Rehabilitation 6Cord Blood Stem Cell Transplantation 6Bortezomib 6Transplantation 5Sirolimus 5Polymerase Chain Reaction 5Gemcitabine 5Everolimus 5Brentuximab Vedotin 5Alemtuzumab 5pembrolizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Sezary Syndrome × Lymphatic Irradiation × Clear all
NCT00896493 2023-05-11

Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

Stanford University

Phase 2 Completed
38 enrolled 21 charts
DermatologicLymphoid

Lymphoma, Non-Hodgkin, Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡